Sam Chun Dang Pharm. Co. Ltd.
This is a single-arm, multicenter study to evaluate clinical usability of a pre-filled syringe containing SCD411 in adult patients with neovascular Wet Age-Related Macular Degeneration (AMD), Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), or Diabetic Retinopathy (DR)
Inclusion Criteria: Providers must meet all of the following criteria to be eligible for the study: * Be an ophthalmologist with a retinal specialty or with IVT training * Be board-certified by the American Board of Ophthalmology * Be licensed to practice medicine in the state where patients are seen * Be able to conduct physical examinations, including but not limited to ophthalmic examinations, on patients prior to and after injection * Have access to appropriate tools and equipment for pre- and post-injection examinations and monitoring Patients must meet all of the following criteria to…
Single intravitreal therapy (IVT) injection using a prefilled syringe (PFS)
Arctuva estimate
Verify or correct the compensation shown for this listing.